Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues (Q42971072)

12 November 2017

title

Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues (English)

1 reference

12 November 2017

1 reference

Sun Jung Kim

1

1 reference

12 November 2017

Han-Sung Kang

2

1 reference

12 November 2017

So-Youn Jung

3

1 reference

12 November 2017

Sun Young Min

4

1 reference

12 November 2017

Seeyoun Lee

5

1 reference

12 November 2017

Seok Won Kim

6

1 reference

12 November 2017

Youngmee Kwon

7

1 reference

12 November 2017

Keun Seok Lee

8

1 reference

12 November 2017

Kyung Hwan Shin

9

1 reference

12 November 2017

Jungsil Ro

10

1 reference

12 November 2017

publication date

14 July 2010

1 reference

Journal of Molecular Medicine

12 November 2017

published in

1 reference

12 November 2017

volume

88

1 reference

12 November 2017

issue

11

1 reference

12 November 2017

page(s)

1123-1131

1 reference

The history of cancer epigenetics

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0652-Z

Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0652-Z

Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0652-Z

Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-010-0652-Z

Basic guide to the mechanisms of antiestrogen action

21 January 2018

1 reference

12 December 2020

Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer.

1 reference

12 December 2020

Analysis of cag-8: a novel poly(Q)-encoding gene in the mouse brain

1 reference

12 December 2020

Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.

1 reference

12 December 2020

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

12 December 2020

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

12 December 2020

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.

1 reference

12 December 2020

Standard medical treatment for early breast cancer

1 reference

12 December 2020

Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells

1 reference

12 December 2020

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

12 December 2020

Cancer epigenomics: DNA methylomes and histone-modification maps

1 reference

12 December 2020

Classification of breast cancer using genetic algorithms and tissue microarrays

1 reference

12 December 2020

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

12 December 2020

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays

1 reference

12 December 2020

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma

1 reference

12 December 2020

Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli

1 reference

12 December 2020

Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines.

1 reference

12 December 2020

Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors

1 reference

12 December 2020

Gene silencing in cancer in association with promoter hypermethylation

1 reference

12 December 2020

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

12 December 2020

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

12 December 2020

Pharmacogenetics of the arylamine N-acetyltransferases.

1 reference

12 December 2020

10.1007/S00109-010-0652-Z

Identifiers

DOI

1 reference

12 November 2017

1 reference